Diagnosing pulmonary MALT lymphoma: a case of unilateral cystic lesions.
We present an atypical case of a 62-year-old female diagnosed with pulmonary mucosa-associated lymphoid tissue (p-MALT) lymphoma, which uniquely manifested as a singular cystic lesion in the lung.
APA
Li P, Huang Z, et al. (2025). Diagnosing pulmonary MALT lymphoma: a case of unilateral cystic lesions.. Future science OA, 11(1), 2497214. https://doi.org/10.1080/20565623.2025.2497214
MLA
Li P, et al.. "Diagnosing pulmonary MALT lymphoma: a case of unilateral cystic lesions.." Future science OA, vol. 11, no. 1, 2025, pp. 2497214.
PMID
40293107
Abstract
We present an atypical case of a 62-year-old female diagnosed with pulmonary mucosa-associated lymphoid tissue (p-MALT) lymphoma, which uniquely manifested as a singular cystic lesion in the lung. Diagnostic evaluations, including comprehensive imaging, bronchoscopy, and CT-guided lung biopsy, revealed this uncommon radiological presentation. Detailed histopathological and immunohistochemical assessments further supported the diagnosis. To determine the extent of the disease, systemic evaluations, such as whole-body PET-CT, gastroscopy, colonoscopy, and bone marrow biopsy, were conducted, confirming its localized nature. Following the definitive diagnosis, the patient underwent a rituximab-centric therapeutic regimen, which yielded significant clinical improvement. This case highlights the importance of recognizing distinctive cystic lung features in p-MALT lymphoma and the indispensable role of holistic diagnostic approaches in guiding precise therapeutic and prognostic decisions.
같은 제1저자의 인용 많은 논문 (5)
- Association of PD-L1 and PD-1 Expression With Clinicopathological Characteristics and Prognosis in Upper Tract Urothelial Carcinoma.
- Light-promoted engineered bacterial DNase I therapeutic intervention to enable potent cancer photoimmunotherapy.
- SLC13 sodium-carboxylate transporters: function, regulation and pathophysiological implications in human disease.
- Poly (ADP-ribose) polymerase 1-targeted photosensitizer as a dual-activator of pyroptosis and the STING pathway for enhanced cancer photoimmunotherapy.
- Engineered Bacteria-Driven Biohybrid Microrobots Potentiate IL-2 Immunotherapy by Evoking Pyroptosis.